Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K252391

    Validate with FDA (Live)

    Device Name
    Revi System
    Date Cleared
    2025-12-12

    (134 days)

    Product Code
    Regulation Number
    876.5305
    Age Range
    22 - 120
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.

    Device Description

    The Revi System is an implanted tibial electrical urinary continence device that wirelessly receives power from a non-implanted external wearable unit to provide electrical stimulation of the tibial nerve in proximity to the ankle. The device is intended for the treatment of urgency incontinence, alone or in combination with urinary urgency.

    The implantable device is implanted in the vicinity of the tibial neurovascular bundle. The treatment effect of the system is achieved by the implantable wireless neurostimulation component, which sends pulses to the tibial nerve when energized by the wearable unit transmitted power. The electrical pulses stimulate the nerve along the leg, reaching the sacral plexus and entering the spinal cord. This stimulation is theorized to have the power to modulate nerve function, relieving symptoms.

    The modifications reported in this 510(k) submission include introducing an updated Wearable Unit, an associated software update to support the updated Wearable Unit and related labeling. These modifications do not affect the implantable component of the Revi System or the indications for use.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1